Seagen Inc (NASDAQ:SGEN)
| 212.70 Delayed Data As of 3:59pm ET |  -0.51 / -0.24%Today’s Change | 116.08 Today|||52-Week Range 217.51 | +65.51% Year-to-Date |
Latest SGEN News | Press Releases
| Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report? 11:32am / Zacks.com - Paid Partner Content | Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag 7:42am / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 213.21 |
| Today’s open | 213.21 |
| Day’s range | 212.45 - 213.77 |
| Volume | 48,519 |
| Average volume (3 months) | 1,298,459 |
| Market cap | $40.3B |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +10.80% |
| Earnings growth (this year) | +11.21% |
| Earnings growth (next 5 years) | +66.10% |
| Revenue growth (last year) | +24.65% |
| P/E ratio | NM |
| Price/Sales | 12.09 |
| Price/Book | 14.27 |
Financials
| Next reporting date | February 8, 2024 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $2.0B |
| Annual profit (last year) | -$610.3M |
| Net profit margin | -31.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bothell, Washington |
Forecasts
